Chromosome substitution strain assessment of a Huntington’s disease modifier locus
暂无分享,去创建一个
T. Gillis | J. Mysore | M. MacDonald | V. Wheeler | I. Alonso | J. Sequeiros | E. Ramos | M. Kovalenko | Jason St. Claire | Jolene R. Guide
[1] Edith T. Lopez,et al. A Broad Phenotypic Screen Identifies Novel Phenotypes Driven by a Single Mutant Allele in Huntington’s Disease CAG Knock-In Mice , 2013, PloS one.
[2] Laurent Gil,et al. Ensembl 2013 , 2012, Nucleic Acids Res..
[3] T. Gillis,et al. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. , 2012, Cell stem cell.
[4] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[5] Judith A. Blake,et al. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse , 2011, Nucleic Acids Res..
[6] T. Gillis,et al. Quantification of Age-Dependent Somatic CAG Repeat Instability in Hdh CAG Knock-In Mice Reveals Different Expansion Dynamics in Striatum and Liver , 2011, PloS one.
[7] M. Daly,et al. Genetic resistance to diet-induced obesity in chromosome substitution strains of mice , 2010, Mammalian Genome.
[8] Jie Zhang,et al. A novel approach to investigate tissue-specific trinucleotide repeat instability , 2010, BMC Systems Biology.
[9] M. MacDonald,et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models , 2009, Neurobiology of Disease.
[10] M. MacDonald,et al. Huntington's disease: the case for genetic modifiers , 2009, Genome Medicine.
[11] J. Willey,et al. PRESTROKE PHYSICAL ACTIVITY IS ASSOCIATED WITH SEVERITY AND LONG-TERM OUTCOME FROM FIRST-EVER STROKE , 2009, Neurology.
[12] K. Marder,et al. Dietary intake in adults at risk for Huntington disease , 2009, Neurology.
[13] M. Chesselet,et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice , 2008, Neuroscience.
[14] T. Stijnen,et al. Weight loss in Huntington disease increases with higher CAG repeat number , 2008, Neurology.
[15] L. Cardon,et al. Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds , 2008, Genetic epidemiology.
[16] Jane S. Paulsen,et al. Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study , 2006, BMC Medical Genetics.
[17] R. Barker,et al. Weight changes in Huntington's disease , 2006, European journal of neurology.
[18] Edith T. Lopez,et al. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. , 2006, Human molecular genetics.
[19] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[20] Eric S. Lander,et al. Genetic Dissection of Complex Traits with Chromosome Substitution Strains of Mice , 2004, Science.
[21] Jane S. Paulsen,et al. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16 , 2004, Neurogenetics.
[22] Karen Marder,et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Ochoa,et al. Assessment of the nutrition status of patients with Huntington's disease. , 2004, Nutrition.
[24] Jane S. Paulsen,et al. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. , 2003, American journal of human genetics.
[25] E. Simpson,et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. , 2003, Human molecular genetics.
[26] M. MacDonald,et al. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. , 2003, Human molecular genetics.
[27] K. Marder,et al. Weight loss in early stage of Huntington’s disease , 2002, Neurology.
[28] M. MacDonald,et al. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. , 2002, Human molecular genetics.
[29] R. Albin,et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. , 2001, Human molecular genetics.
[30] C. Blakemore,et al. N‐Acetylaspartate and DARPP‐32 levels decrease in the corpus striatum of Huntington's disease mice , 2000, Neuroreport.
[31] P. Greengard,et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] E. Lander,et al. Analysing complex genetic traits with chromosome substitution strains , 2000, Nature Genetics.
[33] M. MacDonald,et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. , 2000, Human molecular genetics.
[34] Jacqueline K. White,et al. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. , 1999, Human molecular genetics.
[35] Jacqueline K. White,et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion , 1997, Nature Genetics.
[36] J. Penney,et al. Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.
[37] M. MacDonald,et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.
[38] M. Hayden,et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.
[39] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[40] D. Sax,et al. Factors associated with slow progression in Huntington's disease. , 1991, Archives of neurology.
[41] L. M. Morales,et al. Nutritional evaluation of Huntington disease patients. , 1989, The American journal of clinical nutrition.
[42] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[43] L. Farrer,et al. Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease. , 1985, American journal of medical genetics.
[44] H. Fibiger,et al. BODY WEIGHT AND DIETARY FACTORS IN HUNTINGTON'S DISEASE PATIENTS COMPARED WITH MATCHED CONTROLS , 1981, The Medical journal of Australia.